BioCardia, Inc.
NASDAQ Capital MarketTotal Valuation
BioCardia, Inc. carries a market capitalization of 10,116.00, placing it among publicly traded companies globally. Its enterprise value stands at -539,000.00, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 10,116.00 |
| Enterprise Value | -539,000.00 |
Share Statistics
BioCardia, Inc. currently has 10.94M shares outstanding.
| Shares Outstanding | 10.94M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Financial Position
BioCardia, Inc. maintains a current ratio of 0.41, meaning it holds 0.4x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.41 |
| Quick Ratio | 0.35 |
| Debt / Equity | -38.65 |
| Debt / EBITDA | -0.05 |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -400.98 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
BioCardia, Inc.'s stock has declined approximately -97.96667% over the past 52 weeks. The 50-day moving average sits at - -, while the 200-day moving average is - -.
| Beta (5Y) | N/A |
| 52-Week Price Change | -97.96667% |
| 50-Day Moving Average | - - |
| 200-Day Moving Average | - - |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -7.80M, while operating income came in at -7.82M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -7.82M |
| Pretax Income | -7.77M |
| Net Income | -7.77M |
| EBITDA | -7.80M |
| EBIT | -7.82M |
| Earnings Per Share (EPS) | N/A |
Balance Sheet
BioCardia, Inc. holds 951,000.00 in cash and equivalents against 412,000.00 in total debt, resulting in a net debt position of -951,000.00. Total book value stands at -170.60M, with working capital of -1.64M providing operational flexibility.
| Cash & Cash Equivalents | 951,000.00 |
| Total Debt | 412,000.00 |
| Net Debt | -951,000.00 |
| Equity (Book Value) | -170.60M |
| Book Value Per Share | N/A |
| Working Capital | -1.64M |
Cash Flow
BioCardia, Inc. produced -7.48M in operating cash flow over the past twelve months.
| Operating Cash Flow | -7.48M |
| Capital Expenditures | -10,000.00 |
| Free Cash Flow | -7.49M |
| FCF Per Share | N/A |
Scores
BioCardia, Inc. posts an Altman Z-Score of -155.73, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -155.73 |